| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2001 | CA2382216A1 Method to produce powders for pulmonary or nasal administration |
| 03/01/2001 | CA2381571A1 Phospholipid gel |
| 03/01/2001 | CA2381468A1 Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381302A1 Drug for treating fractures |
| 03/01/2001 | CA2381111A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2380524A1 Compositions and methods for treating opiate intolerance |
| 03/01/2001 | CA2380513A1 Methods for treatment of mental disorders |
| 03/01/2001 | CA2379982A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376606A1 Active substance combination with clonidine |
| 03/01/2001 | CA2376509A1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | CA2376269A1 Process for producing fine medicinal substances |
| 03/01/2001 | CA2376180A1 Oral liquid compositions |
| 03/01/2001 | CA2345618A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 03/01/2001 | CA2316767A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 02/28/2001 | EP1078928A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/28/2001 | EP1078927A1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 02/28/2001 | EP1078925A1 4-Phenylpiperidine compounds |
| 02/28/2001 | EP1078637A2 Composition for the treatment and prevention of nicotine addiction containing a nicotine receptor agonist and an anti-depressant or anti-anxiety drug |
| 02/28/2001 | EP1078636A1 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 02/28/2001 | EP1078635A2 Medicaments comprising sialic acid derivatives as active ingredients |
| 02/28/2001 | EP1078634A1 Medicament for inhibiting NF-kB |
| 02/28/2001 | EP1078633A2 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 02/28/2001 | EP1078632A1 Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| 02/28/2001 | EP1078631A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis |
| 02/28/2001 | EP1078630A1 Use of sigma receptor agonists for the treatment of depression |
| 02/28/2001 | EP1078629A2 Use of Salmeterol and salts for the treatment of inflammation and allergy |
| 02/28/2001 | EP1078628A2 Multiple unit tableted dosage form |
| 02/28/2001 | EP1078627A1 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 02/28/2001 | EP1078092A2 Expression vectors for stimulating an immune response and methods of using the same |
| 02/28/2001 | EP1078079A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078053A2 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077992A1 Meiosis regulating compounds |
| 02/28/2001 | EP1077988A1 Crystal form 0 of clarithromycin |
| 02/28/2001 | EP1077986A2 Improvements in macrolide production |
| 02/28/2001 | EP1077985A1 Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides |
| 02/28/2001 | EP1077984A1 2"-deoxy hygromycin derivatives |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP1077981A1 Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same |
| 02/28/2001 | EP1077980A2 Epothilone derivatives, a method for the production thereof, and their use |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077977A1 Retroviral protease inhibiting compounds |
| 02/28/2001 | EP1077976A1 Water soluble azoles as broad-spectrum antifungals |
| 02/28/2001 | EP1077975A1 Water soluble azoles as broad-spectrum antifungals |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077973A2 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077970A1 11-aryl-benzo(b)naphtho(2,3-d)furans and 11-aryl-benzo(b)naphtho(2,3-d)thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077969A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077968A1 Naphtho[2,3-b]heteroar-4-yl derivatives |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077966A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077965A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077964A1 Fumagillol derivatives and processes for preparing the same |
| 02/28/2001 | EP1077960A1 (2-acylaminothiazole-4-yl)acetic acid derivatives |
| 02/28/2001 | EP1077959A1 Morpholino ethers |
| 02/28/2001 | EP1077958A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077956A1 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity |
| 02/28/2001 | EP1077950A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 02/28/2001 | EP1077949A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 02/28/2001 | EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/28/2001 | EP1077947A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077942A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 02/28/2001 | EP1077941A1 Compounds with growth hormone releasing properties |
| 02/28/2001 | EP1077940A1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 02/28/2001 | EP1077937A1 METHOD OF LOCKING 1$g(a)-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 02/28/2001 | EP1077936A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 02/28/2001 | EP1077935A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 02/28/2001 | EP1077933A1 Substituted guanidines and diaminonitroethenes, their preparation and use |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077930A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/28/2001 | EP1077920A1 New compounds, their preparation and use |
| 02/28/2001 | EP1077919A1 New compounds, their preparation and use |
| 02/28/2001 | EP1077912A1 Novel derivatives of 3,3-diphenylpropylamines |
| 02/28/2001 | EP1077729A2 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 02/28/2001 | EP1077724A2 Methods and products related to metabolic interactions in disease |
| 02/28/2001 | EP1077722A2 Methods and products for inducing mucosal immunity |
| 02/28/2001 | EP1077718A1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 02/28/2001 | EP1077716A1 Method for the treatment of gastroesophageal reflux disease |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077714A1 Use of arabinoxylans for preparing a composition |
| 02/28/2001 | EP1077711A2 Treatment of papilloma virus infection using a mycobacterium |
| 02/28/2001 | EP1077709A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/28/2001 | EP1077708A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |